5 Key Takeaways

• 1

  BAK-containing glaucoma drops provide antimicrobial effects but can worsen dry eye disease, leading to patient nonadherence.

• 2

  Nonadherence to preserved drops is nearly three times higher than to preservative-free alternatives, increasing the risk of vision loss.

• 3

  Long-term use of BAK-containing medications can cause corneal staining, chronic inflammation, and meibomian gland dysfunction.

• 4

  A new prescribing mindset suggests using selective laser trabeculoplasty as a first-line treatment for patients with dry eye disease.

• 5

  Improving dry eye disease management can enhance glaucoma treatment outcomes, emphasizing the importance of each prescribed drop.